GOT2 and hepatocellular carcinoma: Among the 19 MRGs screened, we selected six (GAD1, SPP1, WFS1, GOT2, EHHADH, and APOA1) that have not been reported extensively in HCC, and their transcription levels and association with clinicopathological features were analyzed.